Get the app
USHealthcare

Certara Inc (CERT)

US · Healthcare · Health Information Services

$8.58+5.54%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$93.3M
Revenue YoY
-10.8%
Net profit
$-55.3M
EPS
$0.05
EPS estimate
$0.06
Net margin
-59.3%

EPS came in at 0.05 against a street estimate of 0.06 — a miss of 16.7%.

Key statistics

Market cap
$1.22B
Forward P/E
12.7
P/B
1.19
Book value
$6.34
EPS (TTM)
$-0.14
52-week high
$13.88
52-week low
$4.45
50-day MA
$7.73
200-day MA
$7.20
Beta
1.41

Analyst view

Analysts rate Certara Inc a buy (5 buy, 6 hold, 0 sell out of 11) with an average price target of $8.34.

Shareholding

Insiders
2.73%
Institutions
112.93%

Largest institutional holders

FundStake
BlackRock Inc9.38%
Deerfield Management Co5.12%
Haveli Investment Management LLC4.85%
Jefferies Financial Group Inc4.50%
Dimensional Fund Advisors, Inc.3.95%
Vanguard Portfolio Management, LLC3.91%
Vanguard Capital Management, LLC3.51%
Wasatch Advisors LP2.82%

Recent filings & reports

DocumentDate
Reg FD disclosure · Q3 2026
CERTARA, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Company clarified a misstatement made during Q2 2026 earnings conference call on August 4, 2026
2026-08-07
Quarterly report · Q2 2026
CERTARA, INC. – FORM 10-Q SUMMARY (Q2 2026) HEADLINE NUMBERS • Revenue (6 months): $187.363 million vs. $184.455 million prior year (+1.6%) • Revenu
2026-08-04
Results announced · Q3 2026
CERTARA, INC. – Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Total Revenue Q2 2026: $93.3 million, up 1% year-over-year vs. $92.4 million in Q2 2025
2026-08-04
Board / officer change · Q3 2026
CERTARA, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • No financial metrics or performance data disclosed in this filing • This is a current report on
2026-08-04
Board / officer change · Q2 2026
CERTARA, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • No material financial figures or numerical guidance disclosed in this Form 8-K filing • Document
2026-06-17
Quarterly report · Q1 2026
CERTARA, INC. – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Revenue Q1 2026: $106.915 million (vs. $106.004 million in Q1 2025) – essentially flat year-
2026-05-11
Proxy statement · Q2 2026
CERTARA, INC. PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Election of Class III Directors – Vote FOR each of three nominee
2026-04-03
Annual report FY2025
CERTARA, INC. – 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Company: Certara, Inc. (ticker: CERT, Nasdaq) • Fiscal year ended: December 31,
2026-02-26

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Certara Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.